GlassScriptPhysician profile
Catherine A Lucas
NPI 1184160038
$1,178.30
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $867 · 2022: $297 · 2023: $13.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $197.84 | 2021-2022 | |
| Abbvie INC. | $169.56 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $143.84 | 2021-2022 | |
| Lilly USA, LLC | $128.55 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.99 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $74.58 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $55.25 | 2021 | |
| Eisai INC. | $43.86 | 2021 | |
| Pfizer INC. | $38.70 | 2021-2022 | |
| Edwards Lifesciences Corporation | $35.09 | 2022 | |
| Amarin Pharma, INC. | $31.69 | 2021-2022 | |
| Glaxosmithkline, LLC. | $27.63 | 2021 | |
| Merck Sharp & Dohme LLC | $25.70 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $24.56 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $22.30 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $16.28 | 2021 | |
| Abbott Laboratories | $14.98 | 2022 | |
| Stryker Corporation | $13.90 | 2023 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Lucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.